Cargando…

LBODP016 Lithocholic Acid Induced 25-hydroxyvitamin D-1alpha Hydroxylase (cyp27b1) Expression And Activities In Vitro And In Vivo

Our previous study reported that oleanolic acid, a natural agonist for bile acid membrane receptor Takeda G protein coupled receptor 5 (TGR5), could exert bone protective effects, increase circulating 1, 25(OH)2D3 level and induce renal CYP27B1 expression and activities. However, it is unclear if bi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lam, Chung Yan, Yu, Wenxuan, Kong, Tsz Hung, Wong, Man-Sau
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Bone & Mineral Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624829/ http://dx.doi.org/10.1210/jendso/bvac150.293

Ejemplares similares

Oleanolic Acid Modulates 25-Hydroxyvitamin D(3) 1-alpha-hydroxylase in Osteoblasts and Human Mesenchymal Stem Cells
por: Yu, Wen-Xuan, et al.
Publicado: (2021)

LBODP021 Multifactorial Hypercalcemia
por: Ramachandran, Aishwarya, et al.
Publicado: (2022)

MON-339 Secondary Hyperparathyroidism Due to Decrease 1 Alpha Hydroxylase Activity
por: Bahlol, Maimoona, et al.
Publicado: (2020)

PSAT217 Estrogen Deficiency as a Cause of Decreased 1- alpha - hydroxylase Activity
por: Sviderskaya, Tatiana
Publicado: (2022)

LBODP065 Rare Cause Of Bone Pain In MEN Syndrome
por: Ramdhanie, Lisa Indira, et al.
Publicado: (2022)

LBODP018 Hypercalcemia In A Child On Ketogenic Diet For Intractable Epilepsy
por: Gurnurkar, Shilpa, et al.
Publicado: (2022)

THU398 Variants In The Vitamin D Receptor, 1alpha-hydroxylase Enzyme Genes In Cholecalciferol Therapy
por: Kalinchenko, Svetlana, et al.
Publicado: (2023)

LBODP020 Treatment Of Hypercalcemia Due To Prolonged, Excessive Vitamin D Intake
por: Abdelrahman, Houda, et al.
Publicado: (2022)

LBODP022 A Rare Case Of Hypercalcemia: Mycobacterium Avium Complex Induced Hypercalcemia
por: Aluko, Oluwatomisin A, et al.
Publicado: (2022)

LBODP017 Unusual Presentation Of Brown Tumors In Tertiary Hyperparathyroidism: A Case-based Review
por: ALShehri, Sara Mohammed, et al.
Publicado: (2022)

SAT-495 1-α-Hydroxylase Activity-Mediated Hypercalcemia Associated with Ovarian Dysgerminoma
por: Subbu, Karthik, et al.
Publicado: (2019)

Characteristics of Serum Ratios of 1,25-Dihydroxyvitamin D to 25-Hydroxyvitamin D for Assessment of Bone Metabolism
por: Yamamoto, Koichiro, et al.
Publicado: (2021)

LBSAT130 Hypercalcemia In Pregnancy Due To CYP24A1 Mutation
por: Agu, Chinyere, et al.
Publicado: (2022)

LBODP023 Popular Supplements Containing Plant Extracts With High Biotin Content Can Severely Impact Parathyroid Hormone (PTH) Measurements Leading To A False Suspicion Of Primary Hyperparathyroidism (PHP).
por: Wozniak, Zofia, et al.
Publicado: (2022)

THU406 24-hydroxylase Deficiency, A Rare Cause Of Hypercalcemia
por: Hodge, Jordesha, et al.
Publicado: (2023)

SAT-368 CYP24A1 Mutation Masking Malignancy Mediated Hypercalcemia
por: Cheng, Cheng, et al.
Publicado: (2020)

Importance of Extra-Renal CYP24A1 Expression for Maintaining Mineral Homeostasis
por: Shi, Melody, et al.
Publicado: (2021)

THU397 Homeostatic Regulation Of 1,25-dihydroxyvitamin D: Critical Role Of 24-hydroxylation (CYP24A1)
por: Yazdi, Zhinoosossadat Shahidzadeh, et al.
Publicado: (2023)

SAT252 Homozygous CYP24A1 Gene Mutation Induced Hypercalcemia During Pregnancy
por: Ankireddypalli, Anvitha Reddy, et al.
Publicado: (2023)

Lack of Association Between 25-Hydroxyvitamin D Level and Outcomes in Hospitalized Indian Patients With COVID-19
por: Jevalikar, Ganesh, et al.
Publicado: (2021)

LBSAT229 Extended-release Calcifediol Effectively Raised 25-hydroxyvitamin D In CKD Despite Obesity
por: Strugnell, Stephen A, et al.
Publicado: (2022)

Coexistent CYP24A1 and PHEX Gene Mutations With Hypervitaminosis D Plus Hypercalcemia Treated With Fluconazole
por: Bawden, David, et al.
Publicado: (2021)

A Comparison of Free and Total 25-hydroxyvitamin D Levels as Functional Indicators of Bone Health in Healthy Children
por: Heo, You Joung, et al.
Publicado: (2021)

THU472 Novel And Multifactorial Case Of Severe Hypercalcemia Due To Primary Hyperparathyroidism And Heterozygous Mutation Of CYP24A1
por: Liu, Jannel, et al.
Publicado: (2023)

ODP096 Hypercalcemia Secondary to Vitamin D Supplementation with Normal 25-Hydroxyvitamin D Level in an Elderly Female - Case Report
por: Arora, Gunjan, et al.
Publicado: (2022)

SAT-514 The Decrease in Serum Parathyroid Hormone on Vitamin D Treatment Is Similar When Comparing Increases in Serum Free or Total 25 Hydroxyvitamin D in White and Black Women
por: Smith, Lynette, et al.
Publicado: (2019)

SAT178 EZH2 Upregulation And Lysine 27 Trimethylation at Histone 3 Is Associated With Severe Sporadic Primary Hyperparathyroidism
por: Kumari, Poonam, et al.
Publicado: (2023)

OR27-02 The Bone Anabolic Effect Of An Antibody Blocking Oxidized Phospholipids Is Associated With An Increase In Wnt10b In Osteoblasts.
por: Palmieri, Michela, et al.
Publicado: (2023)

OR30-5 Germline Ablation of G-Protein Subunit Alpha-11 in Mice Causes Hypercalcemia That Is Rectified by Treatment with Cinacalcet
por: Hannan, Fadil, et al.
Publicado: (2019)

Hip Geometry Variation in Homozygous Ectonucleotide Pyrophosphatase/ Phosphodiesterase 1 (ENPP1) Deficient Patients
por: Theng, Elizabeth H, et al.
Publicado: (2021)

MON-374 Management of 1,25-dihydroxyvitamin D (1,25-OHD) Mediated Hypercalcemia of Unknown Etiology
por: Menon, Sruthi, et al.
Publicado: (2020)

SAT-404 Neonatal Hypocalcemic Seizures in Offspring of a Mother with Familial Hypocalciuric Hypercalcemia Type 1 (FHH1)
por: Hannan, Fadil M, et al.
Publicado: (2020)

OR21-4 Comparison of the Effects of PTH (1-34), PTHrP (1-36) and Abaloparatide (ABL) on the Murine Osteoblast Transcriptome
por: He, Zhiming, et al.
Publicado: (2022)

SUN-347 Glucagon-like Peptide 1 (GLP-1) Acts Directly On Human Osteoclasts To Increase Differentiation And Bone Resorptive Activity
por: Hansen, Morten Steen, et al.
Publicado: (2020)

A Case of Pseudohypoparathyroidism Type 1b in Pregnancy
por: Balasubramanian, Priyadarshini, et al.
Publicado: (2021)

LBSAT142 Discovery And Characterization Of A Potent And Orally Bioavailable Parathyroid Hormone Receptor Type-1 (PTHR1) Antagonist For The Treatment Of Hypercalcemia
por: Rico-Bautista, Elizabeth, et al.
Publicado: (2022)

FRI671 Association Of Insulin-like Growth Factor-1 (igf-1) With Bone Mineral Density (bmd) In Survivors Of Childhood Acute Leukemia 
por: Kim, Seulki, et al.
Publicado: (2023)

OR30-1 Safety and Efficacy of Recombinant Human Parathyroid Hormone 1-84 for the Treatment of Adults with Chronic Hypoparathyroidism: Six-Year Results of the RACE Study
por: Bilezikian, John, et al.
Publicado: (2019)

OR07-01 Identification of the First Case of Acquired Autoimmune Parathyroid Hormone (PTH) Resistance Due to PTH1 Receptor (PTH1R) Autoantibodies
por: Mandl, Adel, et al.
Publicado: (2020)

A Phase 2B, Open-Label, Dose-Ranging Study of Encaleret (CLTX-305) in Autosomal Dominant Hypocalcemia Type 1 (ADH1)
por: Gafni, Rachel Ilana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_93gv6qfto3v9oblanhpeuh179t